10 results on '"Camsari G."'
Search Results
2. Epidemiology and distribution of interstitial lung diseases in Turkey
- Author
-
Musellim B., Okumus G., Uzaslan E., Akgün M., Cetinkaya E., Turan O., Akkoclu A., Hazar A., Kokturk N., Calisir H.C., Sever F., Kiter G., Celik G., Bilgin S., Kurutepe M., Uzun O., Tabak L., Ozdemir O., Turker H., Ogus C., Kiral N., Ozkan M., Yalniz E., Camsari G., Dogan T., Yilmaz U., Cildag O., Yildiz F., Hanta I., Oztuna F., Arik D., Goktalay T., Kanmaz D., Yilmaz V., Altiay G., Komurcuoglu B., Ozkan G., Erbaycu A., Dogrul M.I., Ongen G., Tuncay E., Dabak G., Sakar A., Bircan A., Uzel I., Kalpaklioglu F., Gülbay B, Bulbul Y., Gulbanu H., Havlucu Y., Ekici Z., Zamani A., Caglayan B., Kayacan O., Dursunoglu N., and Musellim, B., Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey -- Okumus, G., Istanbul Medical Faculty, Department of Pulmonary Diseases, Istanbul University, Istanbul, Turkey -- Uzaslan, E., Medical Faculty Chest Diseases Department, Uludag University, Bursa, Turkey -- Akgün, M., Department of Chest Diseases, Faculty of Medicine, Atatürk University, Erzurum, Turkey -- Cetinkaya, E., Yedikule Chest Diseases and Chest Surgery Education and Research Hospital, Istanbul, Turkey -- Turan, O., Department of Pulmonary Diseases, Dokuz Eylul University, Medical Faculty, Izmir, Turkey -- Akkoclu, A., Department of Pulmonary Diseases, Dokuz Eylul University, Medical Faculty, Izmir, Turkey -- Hazar, A., Sureyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey -- Kokturk, N., Department of Pulmonary Medicine, Gazi University School of Medicine, Ankara, Turkey -- Calisir, H.C., Sureyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey -- Sever, F., Sifa University, Department of Pulmonary Diseases, Izmir, Turkey -- Kiter, G., Pamukkale University Medical Faculty, Department of Pulmonary Diseases, Denizli, Turkey -- Celik, G., Ankara University School of Medicine, Department of Chest Diseases, Ankara, Turkey -- Bilgin, S., Samsun Chest Diseases and Chest Surgery Hospital, Turkey -- Kurutepe, M., Sureyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey -- Uzun, O., Department of Pulmonary Medicine, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey -- Tabak, L., Istanbul Medical Faculty, Department of Pulmonary Diseases, Istanbul University, Istanbul, Turkey -- Ozdemir, O., Ankara University School of Medicine, Department of Chest Diseases, Ankara, Turkey -- Turker, H., Istanbul Medical Faculty, Department of Pulmonary Diseases, Istanbul University, Istanbul, Turkey -- Ogus, C., Akdeniz University School of Medicine, Department of Respiratory Diseases, Antalya, Turkey -- Kiral, N., Dr.Lutfi Kirdar Kartal Training and Resarch Hospital, Pulmonary Diseases Department, Istanbul, Turkey -- Ozkan, M., Department of Chest Diseases, Gülhane Military Medical School, Ankara, Turkey -- Yalniz, E., Department of Pulmonary Medicine, Dr Suat Seren Education and Research Hospital for Chest Diseases and Thoracic Surgery, Izmir, Turkey -- Camsari, G., Yedikule Chest Diseases and Chest Surgery Education and Research Hospital, Istanbul, Turkey -- Dogan, T., Department Of Chest Disease, Faculty Of Medicine, Cumhuriyet University, Sivas, Turkey -- Yilmaz, U., Department of Pulmonary Medicine, Dr Suat Seren Education and Research Hospital for Chest Diseases and Thoracic Surgery, Izmir, Turkey -- Cildag, O., Adnan Menderes Universtiy Medical Faculty, Department of Chest Diseases, Aydin, Turkey -- Yildiz, F., Chest Diseases Department of Kocaeli University Medical Faculty, Kocaeli, Turkey -- Hanta, I., Department of Chest Diseases, Faculty of Medicine, University of Cukurova, Adana, Turkey -- Oztuna, F., Department of Chest Diseases, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey -- Arik, D., Department of Chest Diseases, Gülhane Military Medical School, Ankara, Turkey -- Goktalay, T., Celal Bayar University Medical Faculty Department of Pulmonology, Manisa, Turkey -- Kanmaz, D., Yedikule Chest Diseases and Chest Surgery Education and Research Hospital, Istanbul, Turkey -- Yilmaz, V., Yedikule Chest Diseases and Chest Surgery Education and Research Hospital, Istanbul, Turkey -- Altiay, G., Trakya University Medical Faculty Department of Pulmonary Diseases, Edirne, Turkey -- Komurcuoglu, B., Department of Pulmonary Medicine, Dr Suat Seren Education and Research Hospital for Chest Diseases and Thoracic Surgery, Izmir, Turkey -- Ozkan, G., Yedikule Chest Diseases and Chest Surgery Education and Research Hospital, Istanbul, Turkey -- Erbaycu, A., Department of Pulmonary Medicine, Dr Suat Seren Education and Research Hospital for Chest Diseases and Thoracic Surgery, Izmir, Turkey -- Dogrul, M.I., Department of Pulmonary Medicine, Baskent University Faculty of Medicine, Ankara, Turkey -- Ongen, G., Department of Pulmonary Diseases, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey -- Tuncay, E., Yedikule Chest Diseases and Chest Surgery Education and Research Hospital, Istanbul, Turkey -- Dabak, G., Sureyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey -- Sakar, A., Celal Bayar University Medical Faculty Department of Pulmonology, Manisa, Turkey -- Bircan, A., Department of Chest Diseases, Faculty of Medicine, Suleyman Demirel University, Isparta, Turkey -- Uzel, I., Department of Chest Diseases, Yenibosna Safa Hospital, Istanbul, Turkey -- Kalpaklioglu, F., Kirikkale University School of Medicine. Department of Pulmonary and Allergic Diseases, Kirikkale, Turkey -- Gülbay, B, Ankara University School of Medicine, Department of Chest Diseases, Ankara, Turkey -- Bulbul, Y., Department of Chest Diseases, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey -- Gulbanu, H., Sureyyapasa Chest Diseases and Thoracic Surgery Education and Research Hospital, Istanbul, Turkey -- Havlucu, Y., Hatay Dortyol State Hospital, Hatay, Turkey -- Ekici, Z., Department of Pulmonary Medicine, Baskent University Faculty of Medicine, Konya, Turkey -- Zamani, A., Department of Pulmonology, Selcuk University, Meram School of Medicine, Konya, Turkey -- Caglayan, B., Dr.Lutfi Kirdar Kartal Training and Resarch Hospital, Pulmonary Diseases Department, Istanbul, Turkey -- Kayacan, O., Ankara University School of Medicine, Department of Chest Diseases, Ankara, Turkey -- Dursunoglu, N., Pamukkale University Medical Faculty, Department of Pulmonary Diseases, Denizli, Turkey
- Subjects
Adult ,Male ,Interstitial lung diseases ,Turkey ,Epidemiology ,disease classification ,Distribution ,Turkey (republic) ,Sarcoidosis, Pulmonary ,middle aged ,Humans ,human ,sarcoidosis ,Prospective Studies ,Aged ,interstitial lung disease ,Incidence ,granulomatosis ,article ,respiratory system ,major clinical study ,Idiopathic Pulmonary Fibrosis ,respiratory tract diseases ,female ,age ,priority journal ,histopathology ,Lung Diseases, Interstitial ,prospective study - Abstract
Introduction: There is very few data on the epidemiological features of interstitial lung diseases (ILD) in the literature. These studies on this subject suffer from limited number of patients. Objective: The goal of this study was to evaluate the epidemiological features of ILD in Turkey. Methods: Fifty-four investigators, 31 centres in 19 cities from six regions of Turkey, participated in the study. Two thousand two hundred forty-five newly diagnosed patients (51.8% females), led by Turkish Thoracic Society Clinical Problems Study Group, enrolled in this prospective study. Results: The mean age was 51.8±16.7 years. The mean age among males was 50.5±18.6 years and 53.0±14.6 years among females (P, Okumus, G.; Istanbul Medical Faculty, Department of Pulmonary Diseases, Istanbul University, 34 390, Capa-Istanbul, Turkey; email: gulferokumus@yahoo.com
- Published
- 2014
3. cell lung cancer in Turkey
- Author
-
Yurdakul, AS, Kocaturk, C, Bayiz, H, Gursoy, S, Bircan, A, Ozcan, A, Akkoclu, A, Uluorman, F, Celik, P, Koksal, D, Ulubas, B, Sercan, E, Ozbudak, O, Goksel, T, Onalan, T, Yamansavci, E, Turk, F, Yuncu, G, Copuraslan, C, Mardal, T, Tuncay, E, Karamustafaoglu, A, Yildiz, P, Secik, F, Kaplan, M, Caglar, E, Ortakoylu, M, Onal, M, Turna, A, Hekimoglu, E, Dalar, L, Altin, S, Gulhan, M, Akpinar, E, Savas, I, Firat, N, Camsari, G, Ozkan, G, Cetinkaya, E, Kamiloglu, E, Celik, B, and Havlucu, Y
- Subjects
Lung cancer ,Delay ,Patient ,Doctor - Abstract
Aim: The early diagnosis and treatment of lung cancer are important for the prognosis of patients with lung cancer. This study was undertaken to investigate patient and doctor delays in the diagnosis and treatment of NSCLC and the factors affecting these delays. Materials and methods: A total of 1016 patients, including 926 (91.1%) males and 90 (8.9%) females with a mean age of 61.5 +/- 10.1 years, were enrolled prospectively in this study between May 2010 and May 2011 from 17 sites in various Turkish provinces. Results: The patient delay was found to be 49.9 +/- 96.9 days, doctor delay was found to be 87.7 +/- 99.6 days, and total delay was found to be 131.3 +/- 135.2 days. The referral delay was found to be 61.6 +/- 127.2 days, diagnostic delay was found to be 20.4 +/- 44.5 days, and treatment delay was found to be 24.4 +/- 54.9 days. When the major factors responsible for these delays were examined, patient delay was found to be more frequent in workers, while referral delay was found to be more frequent in patients living in villages (p < 0.05). We determined that referral delay, doctor delay, and total delay increased as the number of doctors who were consulted by patients increased (p < 0.05). Additionally, we determined that diagnostic and treatment delays were more frequent at the early tumour stages in NSCLC patients (p < 0.05). Discussion: The extended length of patient delay underscores the necessity of educating people about lung cancer. To decrease doctor delay, education is a crucial first step. Additionally, to further reduce the diagnostic and treatment delays of chest specialists, multidisciplinary management and algorithms must be used regularly. (C) 2015 Elsevier Ltd. All rights reserved.
- Published
- 2015
4. Adults: The Asthma Inhaler Treatment Study
- Author
-
Yildiz, F, Erbagci, A, Demirel, YS, Akcali, SD, Ekici, A, Dursunoglu, N, Ediger, D, Erdinc, M, Cemri, SC, Kalyoncu, AF, Guclu, SZ, Aktogu, S, Gurler, BB, Bayram, M, Akgun, M, Mirici, A, Akyildiz, L, Celik, P, Guven, AO, Camsari, G, Ozseker, F, Cimen, F, Kurutepe, M, Senyigit, A, Bektas, Y, Ozbudak, O, Saylan, B, Baslilar, S, Polatli, M, Cagatay, T, Kalkan, S, and Ozer, A
- Subjects
persistent asthma ,inhaler treatment ,inhaler technique ,asthma control ,metered dose inhaler ,dry powder inhaler - Abstract
BACKGROUND: Proper education and training in correct inhalation technique has been reported to have a substantial role in the achievement of optimal therapeutic benefit and asthma control. The present study was designed to evaluate inhaler technique and the role of education in relation to asthma control among patients with persistent asthma in Turkey. METHODS: A total of 572 patients with persistent asthma (mean +/- SD age 42.7 +/- 12.2 y, 76% females) were included in this non-interventional, observational, registry study conducted across Turkey. Data on the effective and correct use of inhaler devices were collected via the Ease of Use for the Inhaler Device Questionnaire to patients and physicians. RESULTS: Asthma control (overall 61.5% at baseline, and increased to 87.3% during follow-up) was better, with significant improvement in technique and decrease in basic errors to the range 0-1, regardless of the inhaler type. Overall, the most common basic error associated with inhalation maneuvers was failure to exhale before inhaling through the device (18.9%). There was concordance between the patients and physicians in the ratio of correct inhaler technique only for spray-type inhalers. CONCLUSIONS: Close follow-up with repeated checking of the patient's inhaler technique and correction of errors each time by a physician seem to be associated with a significant decrease in the percent of patients who make basic errors in inhalation maneuvers and device-independent errors, and with better control of persistent asthma.
- Published
- 2014
5. Long-term Outcome of Patients With Undiagnosed Pleural Effusion.
- Author
-
Gunluoglu G, Olcmen A, Gunluoglu MZ, Dincer I, Sayar A, Camsari G, Yilmaz V, and Altin S
- Subjects
- Adult, Aged, Biopsy, Female, Humans, Male, Middle Aged, Pleural Effusion etiology, Retrospective Studies, Thoracic Surgery, Video-Assisted, Time Factors, Pleural Effusion diagnosis
- Abstract
Introduction: The cause of exudative pleural effusion cannot be determined in some patients. The longterm outcomes of patients with undiagnosed pleural effusion were analyzed., Methods: Patients with exudative pleural effusion whose diagnostic procedures included pleural biopsy using video-assisted thoracoscopic surgery carried out between 2008 and 2012 were evaluated retrospectively. Patients diagnosed with non-specific pleuritis were included. Fifty-three patients with available follow-up data were included in the study., Results: Forty men and 13 women (mean age 53.9±13.9 years) were included. Median follow-up time was 24 months. No diagnosis was given in 27 patients (51%), and a clinical diagnosis was given in 26 patients (49%) during the follow-up period. Malignant disease (malignant mesothelioma) was diagnosed in 2 (3.7%) patients. Other diseases were parapneumonic effusion in 12, congestive heart failure in 8, and miscellaneous in 4 patients. Volume of effusion at the time of initial examination and re-accumulation of fluid after video-assisted thoracoscopic surgery were associated with malignant disease (P=.004 and .0001, respectively)., Conclusion: Although the probability is low, some patients with exudative pleural effusion undiagnosed after pleural biopsy via video-assisted thoracoscopic surgery may have malignant disease. Patients with an initially large volume of effusion that re-accumulates after examination should be closely monitored., (Copyright © 2014 SEPAR. Published by Elsevier Espana. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
6. Ultrasound guided fine-needle aspiration biopsy of metastases in nonpalpable supraclavicular lymph nodes in lung cancer patients.
- Author
-
Kendirlinan R, Ozkan G, Bayram M, Bakan ND, Tutar M, Gür A, and Camsari G
- Abstract
Background and Objectives: To assess frequency and significance of enlarged nonpalpable supraclavicular lymph nodes with routine ultrasound (US) evaluation and US-guided fineneedle aspiration biopsy (FNAB) for the diagnosis and staging of patients with lung cancer., Materials and Methods: 106 consecutive patients with lung cancer and nonpalpable supraclavicular lymph nodes were evaluated with cervical US for the presence of pathological lymph nodes. FNAB was performed in patients with nodes with short-axis > 5 mm, rounded shape and missing echogenic hilum., Results: 27 (25.5%) patients had enlarged supraclavicular lymph nodes on US. Fourteen patients (13.2%) had cytologically proven lymph node involvement. Supraclavicular lymph node metastasis was more frequent in patients with mediastinal invasion (p = 0.0001) and patients with enlarged lymph nodes on upper paratracheal stations on thorax CT (p = 0.0001). No relation was found between supraclavicular lymph node involvement and T stage (p = 0.27), distant metastasis (p = 0.50) or histological type (p = 0.80). Three patients were upstaged from IIIA to IIIB status. US-guided FNAB was the only diagnostic method in 2 patients., Conclusion: US-guided FNAB is a simple and safe procedure which can document N3 stage of disease in lung cancer patients. Thereby more invasive and expensive diagnostic procedures can be avoided in selected lung cancer patients.
- Published
- 2011
- Full Text
- View/download PDF
7. The impact of ultrasonography-guided fine needle aspiration of no palpable supraclavicular lymph nodes on diagnosis and staging in advanced lung cancer.
- Author
-
Ozkan G, Tutar M, Bayram M, Bakan D, Gür A, and Camsari G
- Subjects
- Female, Humans, Lung Neoplasms diagnostic imaging, Lymph Nodes diagnostic imaging, Lymphatic Metastasis diagnosis, Male, Mediastinum, Middle Aged, Neoplasm Staging, Biopsy, Fine-Needle methods, Lung Neoplasms pathology, Lymph Nodes pathology, Ultrasonography, Interventional
- Abstract
Diagnosis and accurate staging of lung cancer is essential for selection of appropriate curative or palliative therapy and affects patient prognosis. Both invasive and non-invasive procedures are used for this purpose. We aimed to assess the frequency of no palpable supraclavicular lymph node metastases in lung cancer patients with enlarged mediastinal lymph nodes, and their impact on diagnosis and staging using ultrasound in this study. Lung cancer patients with no palpable supraclavicular lymph nodes and at least 2 enlarged mediastinal lymph nodes on computerized tomography underwent supraclavicular ultrasound examination. Ultrasound-guided fine needle aspiration (US-guided FNA) was performed when enlarged lymph nodes were present. Supraclavicular lymph node metastasis was confirmed cytologically via US-guided FNA in 16 (40%) of 40 patients. Upper paratracheal lymphadenomegaly was significantly higher in patients with supraclavicular metastases than in those without. No statistical significant differences were observed in the stage, cell types, and metastases of patients with or without supraclavicular metastases. In 3 patients US-guided FNA was used for diagnosis. More than one-third of lung cancer patients with enlarged mediastinal lymph nodes had supraclavicular lymph node metastases in present study. US-guided FNA is an easier, safer, and less invasive procedure than standard techniques used to diagnose lung cancer patients with enlarged mediastinal lymph nodes.
- Published
- 2009
8. [Thoracic findings in neurofibromatosis].
- Author
-
Camsari G, Gür A, Ozkan G, Bakan ND, Zengin F, and Külcü A
- Subjects
- Cough etiology, Diagnosis, Differential, Dyspnea etiology, Female, Humans, Lung Diseases, Interstitial complications, Lung Diseases, Interstitial pathology, Male, Middle Aged, Tomography, X-Ray Computed, Lung Diseases, Interstitial diagnostic imaging, Neurofibromatosis 1 complications, Skin Neoplasms complications
- Abstract
Neurofibromatosis type 1 (von Recklinghausen' disease) is an autosomal dominant hereditary syndrome. It is characterized with multiple light brown (café-au-lait) spots, Lisch nodules and neurofibromas. Thorax and lungs are affected in various forms. Four cases with symptoms of thoracic involvement were investigated in our clinic. Mean age was 46. All cases had dyspnoea and cough; two of them had chest pain. Skin lesions of neurofibromatosis type 1 (NF 1) were pathologically confirmed in all cases. Moreover, case 3 had diffuse interstitial fibrosis and honeycomb pattern. Case 2 had thorax deformity, kyphoscoliosis and intrathoracic benign mass. Case 1 had two neurofibrosarcoma masses on the right hemithorax. Case 4 had multiple intrathoracic neurofibromas. Cases 1 and 3 died within two years after diagnosis due to malignancy and respiratory failure, respectively. Cases 2 and 4 are still under our control.
- Published
- 2006
9. [Churg-Strauss syndrome (two case reports)].
- Author
-
Camsari G, Gür A, Ozkan G, Bakan ND, Kanmaz D, and Yilmazbayhan D
- Subjects
- Adult, Female, Humans, Male, Radiography, Treatment Outcome, Adrenal Cortex Hormones therapeutic use, Churg-Strauss Syndrome diagnostic imaging, Churg-Strauss Syndrome drug therapy
- Abstract
Churg-Strauss syndrome is a necrotizing vasculitis with multiple organ involvement characterized by asthma, peripheral blood eosinophilia, eosinophilic tissue infiltration and extravascular granulomas. A 35 years-old male with 6-months history of asthma and a 43 years-old female with 4-years history of asthma, were further examined due to clinical worsening and lesions on chest radiographs. They were finally diagnosed as Churg-Strauss syndrome. Clinical and radiological response to oral corticosteroid therapy was obtained.
- Published
- 2005
10. Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis.
- Author
-
Onsel C, Sönmezoglu K, Camsari G, Atay S, Cetin S, Erdil YT, Uslu I, Uzun A, Kanmaz B, and Sayman HB
- Subjects
- Adolescent, Adult, Bronchoalveolar Lavage Fluid microbiology, Case-Control Studies, Female, Follow-Up Studies, Humans, Lung diagnostic imaging, Male, Middle Aged, Prospective Studies, Radiography, Radionuclide Imaging, Recurrence, Sensitivity and Specificity, Sputum microbiology, Tuberculosis, Miliary diagnosis, Tuberculosis, Pulmonary diagnosis, Technetium Tc 99m Sestamibi, Tuberculosis, Miliary diagnostic imaging, Tuberculosis, Pulmonary diagnostic imaging
- Abstract
Unlabelled: We investigated the usefulness of 99mTc-methoxyisobutylisonitrile scintigraphy in patients with known or suspected pulmonary tuberculosis (PTB) in comparison with radiological and bacteriological findings., Methods: Thirty-six patients aged 13-59 yr were scanned 15 and 60 min after intravenous injection of 370 MBq (10 mCi) 99mTc-methoxyisobutylisonitrile. Twenty-four patients had active PTB proven by chest radiograph and sputum examinations, two had miliary tuberculosis and ten were suspected of having relapsed PTB with negative sputum examinations and indeterminate chest radiographs. In 12 patients 99mTc-MIBI imaging was repeated 1-3 mo after chemotherapy., Results: Of 24 patients with active localized PTB, 22 (92%) showed increased focal uptake of 99mTc-MIBI, but two patients with minimal infiltration on chest radiographs had no accumulation of 99mTc-MIBI. Both patients with miliary PTB showed diffuse 99mTc-MIBI uptake in the lungs. Among 10 patients with suspicion of relapse, 99mTc-MIBI scans were true-positive in 4 of 5 patients (80%) with culture-proven tuberculosis and false-positive in 2 of 5 (40%) patients with negative sputum cultures. For repeat imaging, 6 of 10 patients with active localized PTB showed reduced MIBI uptake, which correlated with chest radiograph findings, and one patient had increased MIBI uptake again concordant with clinical and radiological findings which were suggestive of resistance to first line chemotherapy of tuberculosis. The other three patients showed no significant scintigraphic changes despite clinical and partial radiological regression., Conclusion: Active PTB granulomas generally present considerable 99mTc-MIBI uptake that is most probably related to disease activity. Therefore, 99mTc-MIBI scanning could be used in the detection and follow-up of active PTB as a complement to routine techniques.
- Published
- 1996
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.